Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent provides contract manufacturing services and performs fill-finish work, which involves the sterile filling and ...

Oct 14 (Reuters) - Catalent (CTLT.N), opens new tab has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug ...

SOMERSET, N.J. - Catalent, Inc. (NYSE ... has reached a definitive agreement to divest its Somerset, New Jersey oral solids development and small-scale manufacturing facility.

SOMERSET, N.J. - Catalent, Inc. (NYSE: NYSE:CTLT), a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has reached a ...

Catalent (CTLT) sells Somerset, NJ facility to Ardena. Corporate headquarters to shift to new location post-transition.

(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on ...